Stay updated on Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.

Latest updates to the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedAn NIH grant/contract note for 2018 was added to the study record, and the page revision was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision label changed from v3.6.4 to v3.6.5, indicating a minor update to the page's version metadata. No substantive content appears to be altered.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page shows a revision update from v3.6.3 to v3.6.4, indicating a small maintenance update to the page.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page's release notes now show Revision: v3.6.3, replacing v3.6.2. This reflects a site update that does not change the study information displayed.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now shows a revision tag of 'Revision: v3.6.2' replacing the previous 'Revision: v3.6.0', indicating a newer version of the page content. The change appears to be a versioning update rather than a substantive alteration to study details.SummaryDifference0.0%

- Check90 days agoChange DetectedRecruitment status now shows 'No longer looking for participants' and new help/navigation sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') have been added. The page footer updates to Revision: v3.6.0 and the Intervention/Treatment heading formatting is updated from 'Intervention / Treatment' to 'Intervention/Treatment'.SummaryDifference0.3%

Stay in the know with updates to Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trastuzumab Deruxtecan+Nivolumab in Breast & Urothelial Cancer Clinical Trial page.